The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study

por Benhabib, Amine, Ioughlissen, Saïd, Ratignier-Carbonneil, Christelle, Maison, Patrick
Publicado 2020

Clinical Trial Authorisation: A Final Look Back to Better Appraise the New European Regulation

por Vignot, Stéphane, Guyader, Gaëlle, Salomon, Valérie, Vella, Philippe, Yoldjian, Isabelle, Maison, Patrick, Ratignier-Carbonneil, Christelle
Publicado 2023

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts

por Maison, Patrick, Zureik, Mahmoud, Hivert, Virginie, Kjaer, Jesper, Hossein Khonsari, Roman, Trifirõ, Gianluca, Ratignier-Carbonneil, Christelle
Publicado 2022

Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A...

por Vignot, Stéphane, Daynes, Pascale, Bacon, Trystan, Vial, Thierry, Montagne, Olivier, Albin, Nicolas, Emmerich, Joseph, Ratignier-Carbonneil, Christelle, Martin, Dominique, Maison, Patrick
Publicado 2021

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

por Vignot, Stéphane, Dhanani, Alban, Sainte-Marie, Isabelle, de Ligniville Lajavardi, Laure, Even, Gwennaelle, Echemann, Muriel, Hulin, Nina, Ménoret, Claire, Maison, Patrick, Ratignier-Carbonneil, Christelle
Publicado 2022

Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience

por Belgodère, Laëtitia, Emmerich, Joseph, Albin, Nicolas, Bacon, Trystan, Daynes, Pascale, Vignot, Stéphane, Vial, Thierry, Renaud, Guillaume, Le Saulnier, Carole, Maillard-Couvreur, Corine, Cachet, Mélanie, Veyries, Marie-Laure, Youdarene, Rym, Oualikene-Gonin, Wahiba, Ratignier-Carbonneil, Christelle, Maison, Patrick
Publicado 2023